Global Vertigo Treatment Market, By Type (Peripheral Vertigo and Central Vertigo), Treatment Type (Medication and Surgery), Drugs (Corticosteroids, Antibiotics, Vestibular Suppressants and Others), Route of Administration (Oral and Injectable), End Users (Hospitals, Homecare, Specialty Clinics and Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights of Vertigo Treatment Market
Data Bridge Market Research analyses that the vertigo treatment will exhibit a CAGR of around 4.70% for the forecast period of 2021-2028. Growing demand for targeted mode of therapies, surge in the research and development activities for the development of novel drugs and therapies, high unmet need of treatment and increased expenditure for the development of healthcare infrastructure are the major factors attributable to the growth of vertigo treatment market.
From the name itself, it is clear the vertigo is a medical condition wherein a person feels that the objects around him or he himself is moving, when it is all still. Vertigo is a common form of dizziness and is often related to walking impairment, sweating, and nausea. It can also be termed as balance disorder.
Growing prevalence of vertigo globally is a major factor fostering the growth of the market. Rising expenditure on the development of healthcare infrastructure, rising emergence of drugs used to treat risk associated with hyperoxaluria and upsurge in the special designation from regulatory authorities are other factors also fostering the growth of the market. Increasing personal disposable income coupled with rising prevalence of sports related injuries is other indirect determinant that will create lucrative market growth opportunities.
However, rising introduction of generic drugs will pose a major challenge to the market growth. Also, high costs associated with research and development proficiencies coupled with shortage of skilled professionals will further derail the market growth rate. Patent expiration of branded drugs will also hamper the market growth rate.
This vertigo treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on vertigo treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Vertigo Treatment Market Scope and Market Size
The vertigo treatment market is segmented on the basis of type, treatment type, drugs, route of administration and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the vertigo treatment market is segmented into peripheral vertigo and central vertigo.
- On the basis of treatment type, the vertigo treatment market is segmented into medication and surgery. Medication segment is sub-segmented into over-the-counter drugs and prescription drugs. Surgery segment is sub-segmented into canal plugging surgery.
- On the basis of drugs, the vertigo treatment market is segmented into corticosteroids, antibiotics, vestibular suppressants and others. Corticosteroids segment is sub-segmented into methylprednisolone. Antibiotics segment is sub-segmented into amoxicillin. Vestibular suppressants segment is sub-segmented into meclizine.
- On the basis of route of administration, the vertigo treatment market is segmented into oral and injectable.
- On the basis of end users, the vertigo treatment market is segmented into hospitals, home care, speciality clinics and others.
Vertigo Treatment Market Country Level Analysis
The vertigo treatment market is segmented on the basis of type, treatment type, drugs, route of administration and end users.
The countries covered in the vertigo treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America dominates the vertigo treatment market owing to the rising affordability of drugs and surge in the cases of vertigo. Asia-Pacific is projected to score highest growth rate and exhibit the highest CAGR for the forecast period. This is because of the rising expenditure to develop healthcare infrastructure and ever-rising geriatric population.
The country section of the vertigo treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
The vertigo treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Vertigo Treatment Market Share Analysis
The vertigo treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to vertigo treatment market.
The major players covered in the vertigo treatment market report are Mylan N.V., Amneal Pharmaceuticals LLC, Epic Pharma, LLC, Endo Pharmaceuticals Inc., Novartis AG, Jubilant Life Sciences Ltd, Pfizer Inc., Vintage Labs, Teva Pharmaceutical Industries Ltd, Zydus Cadila, Lupin., Sagent Pharmaceuticals, Inc., Altamira Therapeutics, Sensorion, Casper Pharma, Indicus Pharma, F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Eli Lilly and Company and Sun Pharmaceutical Industries Ltd. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-